AP Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	15,489	4,223	3,017	-
Market Cap Growth	219.74%	39.97%	-	-
Enterprise Value	14,277	2,559	2,131	-
Last Close Price	181.00	49.75	46.60	-
PS Ratio	-	-	93.55	-
PB Ratio	11.58	2.60	3.85	-
P/TBV Ratio	11.61	2.61	3.87	-
EV/Sales Ratio	-	-	66.08	-
Debt / Equity Ratio	0.05	0.04	0.11	-
Net Debt / Equity Ratio	-0.91	-0.91	-0.84	-0.98
Net Debt / EBITDA Ratio	2.71	3.39	1.91	3.72
Net Debt / FCF Ratio	3.17	4.05	1.98	3.89
Asset Turnover	-	-	0.03	-
Quick Ratio	18.49	39.77	24.77	241.91
Current Ratio	18.55	39.87	24.80	242.10
Return on Equity (ROE)	-	-35.13%	-36.04%	-
Return on Assets (ROA)	-	-20.96%	-21.78%	-
Return on Capital Employed (ROCE)	-32.90%	-26.00%	-40.40%	-27.10%
Earnings Yield	-2.89%	-10.01%	-11.24%	-
FCF Yield	-2.47%	-8.61%	-11.03%	-
Buyback Yield / Dilution	-21.09%	-16.28%	-22.98%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.